Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

News Trending Portfolio

TOOLS

Top Smart Score Stocks

STOCKS

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

Jacobio Pharmaceuticals Group Co., Ltd. (HK:1167)

HKEX:1167

1167

Jacobio Pharmaceuticals Group Co., Ltd.

RESEARCH TOOLS

Top Smart Score Stocks

Stock Screener

reports

Holding HK:1167?

Track your performance easily

Link Broker

Jacobio Pharmaceuticals Group Co., Ltd. (1167) Stock Price & Analysis

2 Followers

1167 Stock Chart & Stats

Advanced Chart >

Day’s RangeHK$0 - HK$0

52-Week RangeHK$1.38 - HK$4.43

Previous CloseHK$1.64

Volume1.01M

Average Volume (3M)1.94M

Market Cap

HK$1.27B

Enterprise ValueN/A

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta1.48

Next Earnings

Mar 26, 2025

EPS Estimate

HK$0.05

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.50

Shares OutstandingN/A

10 Day Avg. Volume844,890

30 Day Avg. Volume1,942,032

Standard Deviation0.18

R-Squared0.18

Alpha-0.02

Financial Highlights & Ratios

Price to Book (P/B)0.00

Price to Sales (P/S)20.79

Price to Cash Flow (P/CF)N/A

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

HK$3.70

Price Target Upside125.61% Upside

Rating ConsensusHold

Number of Analyst Covering1

Jacobio Pharmaceuticals Group Co., Ltd. News

PremiumCompany Announcements

Jacobio Pharmaceuticals Gains EU Orphan Drug Status

1M ago

1167

PremiumCompany Announcements

Jacobio Pharmaceuticals’ Promising Cancer Drug Data

1M ago

1167

PremiumCompany Announcements

Jacobio to Unveil JAB-8263 Clinical Data at ASH 2024

2M ago

1167

PremiumCompany Announcements

Jacobio Pharmaceuticals Secures Major Upfront Payment

2M ago

1167

PremiumCompany Announcements

Jacobio’s New Cancer Drug Enters Clinical Trials

2M ago

1167

PremiumCompany Announcements

Jacobio’s New Cancer Drug Wins FDA Approval

2M ago

1167

PremiumCompany Announcements

Jacobio Pharmaceuticals Reports Productive Interim

3M ago

1167

PremiumCompany Announcements

Jacobio Pharmaceuticals Reveals Board Composition

3M ago

1167

See More HK:1167 News >

Options Prices

Currently, No data available

---

Ownership Overview

―

Insiders

1.37% Mutual Funds

― Other Institutional Investors

97.72% Public Companies and

Individual Investors

Detailed Ownership Overview >

1167 FAQ

What was Jacobio Pharmaceuticals Group Co., Ltd.’s price range in the past 12 months?

Jacobio Pharmaceuticals Group Co., Ltd. lowest stock price was HK$1.38 and its highest was HK$4.43 in the past 12 months.

What is Jacobio Pharmaceuticals Group Co., Ltd.’s market cap?

Currently, no data Available

When is Jacobio Pharmaceuticals Group Co., Ltd.’s upcoming earnings report date?

Jacobio Pharmaceuticals Group Co., Ltd.’s upcoming earnings report date is Mar 26, 2025 which is in 124 days.

How were Jacobio Pharmaceuticals Group Co., Ltd.’s earnings last quarter?

Jacobio Pharmaceuticals Group Co., Ltd. released its earnings results on Aug 30, 2024. The company reported -HK$0.236 earnings per share for the quarter, beating the consensus estimate of -HK$0.29 by HK$0.054.

Is Jacobio Pharmaceuticals Group Co., Ltd. overvalued?

According to Wall Street analysts Jacobio Pharmaceuticals Group Co., Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Jacobio Pharmaceuticals Group Co., Ltd. pay dividends?

Jacobio Pharmaceuticals Group Co., Ltd. does not currently pay dividends.

What is Jacobio Pharmaceuticals Group Co., Ltd.’s EPS estimate?

Jacobio Pharmaceuticals Group Co., Ltd.’s EPS estimate is HK$0.05.

How many shares outstanding does Jacobio Pharmaceuticals Group Co., Ltd. have?

Jacobio Pharmaceuticals Group Co., Ltd. has 791,755,070 shares outstanding.

What happened to Jacobio Pharmaceuticals Group Co., Ltd.’s price movement after its last earnings report?

Jacobio Pharmaceuticals Group Co., Ltd. reported an EPS of -HK$0.236 in its last earnings report, beating expectations of -HK$0.29. Following the earnings report the stock price went up 5.031%.

Which hedge fund is a major shareholder of Jacobio Pharmaceuticals Group Co., Ltd.?

Currently, no hedge funds are holding shares in HK:1167

---

Jacobio Pharmaceuticals Group Co., Ltd. Stock Smart Score

Unlock Smart Score

Analyst Consensus

Hold

Average Price Target:
HK$3.70 (125.61% Upside)

Technicals

Fundamentals

Return on Equity

-33.52%

Trailing 12-Months

Asset Growth

-18.02%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Jacobio Pharmaceuticals Group Co., Ltd.

Jacobio Pharmaceuticals Group Co Ltd is a clinical-stage pharmaceutical company focusing on the in-house discovery and development of innovative oncology therapies.

---

1167 Stock 12 Month Forecast

Average Price Target

HK$3.70

▲(125.61% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"HK$0","1":"HK$1","2":"HK$2","3":"HK$3","4":"HK$4"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":3.7,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$3.70</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3.7,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$3.70</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3.7,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$3.70</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,1,2,3,4],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2024","6":"Apr<br/>2024","9":"Jun<br/>2024","12":"Nov<br/>2024","25":"Nov<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.83,1.973846153846154,2.117692307692308,2.2615384615384615,2.4053846153846155,2.5492307692307694,2.693076923076923,2.836923076923077,2.980769230769231,3.124615384615385,3.2684615384615388,3.4123076923076923,3.556153846153846,{"y":3.7,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.83,1.973846153846154,2.117692307692308,2.2615384615384615,2.4053846153846155,2.5492307692307694,2.693076923076923,2.836923076923077,2.980769230769231,3.124615384615385,3.2684615384615388,3.4123076923076923,3.556153846153846,{"y":3.7,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.83,1.973846153846154,2.117692307692308,2.2615384615384615,2.4053846153846155,2.5492307692307694,2.693076923076923,2.836923076923077,2.980769230769231,3.124615384615385,3.2684615384615388,3.4123076923076923,3.556153846153846,{"y":3.7,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":3.2,"date":1696118400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3.74,"date":1698796800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3.64,"date":1701388800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3.62,"date":1704067200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2.5,"date":1706745600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2.65,"date":1709251200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1.65,"date":1711929600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1.58,"date":1712275200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1.86,"date":1714694400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1.71,"date":1717718400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1.67,"date":1725580800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":2.26,"date":1728000000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1.83,"date":1730419200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >